Skip to main content
. 2021 Aug 4;9:634190. doi: 10.3389/fcell.2021.634190

FIGURE 4.

FIGURE 4

PU-PEI600-Mal-HDT-mediated transfection is not cytotoxic for iPSCs. (A) MTT cell viability assay showing growth/viability of Ctrl-iPSCs treated with the indicated formulations of PU-PEI600/DNA complexes. Data shown as means from three independent experiments with standard deviation error bars. (B) Bright-field images of Ctrl-iPSCs treated with the indicated PU-PEI600/DNA complexes. (C) Comparison of cell viability between untreated Ctrl-iPSCs and Ctrl-iPSCs treated with the indicated PU-PEI600/DNA complexes at different time points of cardiac differentiation (days 0, 15, and 30). Data expressed as mean percentages relative to “Untreated” from three independent experiments with standard deviation error bars.